Home » Illumina Reports Preliminary Q4 Revenues of $260M

Illumina Reports Preliminary Q4 Revenues of $260M

Jan 12, 2011

By a GenomeWeb staff reporter

This article has been updated from a previous version to include additional details from the company's presentation at the JP Morgan Healthcare Conference.

NEW YORK (GenomeWeb News) – Illumina on Tuesday announced preliminary fourth-quarter revenues of approximately $260 million and preliminary full-year 2010 revenue of approximately $901 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

Marks Left on the Genome

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

Cost and Coverage of Gene Therapies

The Wall Street Journal looks into the cost of new gene therapies.

Mosquito Population Crash

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

This Week in PNAS

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

What's Popular?

In Clinical Sequencing

  1. NIH All of Us Program Awards $28.6M to Three Genome Centers Led by Baylor, Broad, UW

  2. New Data Underscores Volatility of Variant Classification, Highlights Need for Regular Reanalysis

  3. Nanopore Sequencing Becomes More Portable to Enable Outbreak Surveillance in Field

    Premium

  4. Geisinger Exome Study IDs Breast Cancer Risk Variants That May Not Have Been Detected in Routine Care

  5. GeneCentric Licenses UNC Pancreatic Cancer Subtyping Tech

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.